"We're proud to be a Semifinalist team of XPRIZE Healthspan, a 7-year, $101 million global competition that aims to ...

Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ future pipeline to focus more on complex generics—drugs that have ...

Q1 2025 Earnings Call Transcript May 7, 2025 The Honest Company, Inc. beats earnings expectations. Reported EPS is $0.03, ...

Adobe's strategic use of AI, including tools like Firefly, enhances its product offerings and deepens customer retention. See ...

Q1 2025 Results Conference Call May 8, 2025 8:30 AM ETCompany ParticipantsJason Wilk - Chief Executive OfficerKyle Beilman - ...

Klink’s revenue model is structured around verified user actions, not passive exposure. At its core, the platform acts as a ...

Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of calendar 2025 -- --With positive Phase 2b QUALITY study, Veru plans for end of Phase 2 ...

The automotive industry is undergoing one of the most profound transformations in its history. Once defined by mechanical ...

We’re also fortunate that TMT has fostered an environment where each team member is encouraged to continually sharpen and ...

Despite short-term headwinds due to customer warehouse overbuilds, we believe the pandemic only accelerated the need for automation given the strong secular trend toward e-commerce. Many of ...

DGIST (President Kunwoo Lee) Department of New Biology Professor Yea Kyungmoo and his research team have developed a next-generation exosome-based drug-delivery technology to effectively treat ...